Cincinnati Children’s, CTI pull plug on Current Biologics project as need wanes, ‘required investment’ soars


Cincinnati Children’s will not proceed with plans to build a new specialized manufacturing facility in the region. The project, first announced in 2021 in conjunction with CTI, was expected to cost in excess of $100 million and add 150 jobs.

Previous Kaiser Permanente Georgia president keeps focus on 'true business objective'
Next Sage market cap cut in half as markets open after partial drug approval